Back to results
US 2004/0204568 A1Published application
Molecules designated LDCAM
AssigneeImmunex Corporation
InventorsPeter Robert Baum, William Christian Fanslow III
Life of this patent
Estimating the term…
Abstract
The invention is directed to LDCAM as a purified and isolated protein, the DNA encoding the LDCAM, host cells transfected with cDNAs encoding LDCAM, processes for preparing LDCAM polypeptides and compositions and methods for treating utilizing LDCAM polypeptides.
Claims5
An isolated DNA sequence encoding a polypeptide that is at least 80% identical with the sequence of amino acid residues selected from the group consisting of 1 to 442 of SEQ ID NO:2 and 1 to 423 of SEQ ID NO:4, the polypeptide being capable of binding to itself.
2-17. (Canceled).
An isolated antibody immunoreactive with LDCAM.
Dependencies are inferred from the claim text.